Department of Justice
Drug Enforcement Administration
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 4, 2002, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
The firm plans to produce bulk product for conversion and distribution to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than December 24, 2002.
| Drug | Schedule |
|---|---|
| Tetrahydrocannabinols (7370) | I |
| Dihydrocodeine (9120) | II |
| Hydromorphone (9150) | II |
| Hydrocodone (9193) | II |
| Noroxymorphone (9668) | II |
| Fentanyl (9801) | II |
Dated: October 21, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.